Yahoo Web Search

Search results

  1. news.abbvie.com › news › abbvie-opens-first-phase-its-globalAbbVie

    AbbVie

  2. Singapore. GLOBAL research and development-based bio-pharmaceutical company AbbVie has enlarged its footprint in Singapore. On Wednesday, it opened a new biologics manufacturing plant in Tuas, which will expand its manufacturing capabilities for biologics, which are commercial products derived from biotechnology.

  3. The JTC Summit. 8 Jurong Town Hall Road. Singapore 609434. Get to know more about Tuas Biomedical Park, a thriving estate for biomedical companies with state-of-the-art facilities and lush green spaces.

  4. Our approach to innovation builds on strong science combined with the drive to find solutions where the need is the greatest. If we bring a new medicine to market, it can help patients worldwide, as opposed to the 20 or so patients we might see in clinic in one day. That's what drives me. It's the greater impact we can have by working here at ...

  5. Sep 30, 2016 · The new 120,000sqm site in the Tuas Biomedical Park is AbbVie’s first manufacturing facility in Asia.

  6. Apr 13, 2021 · 52 million patients in over 175 countries are treated with AbbVie medicines annually. 8 AbbVie R&D centres and 14 manufacturing facilities (one in Singapore) globally. 53 per cent of AbbVie's ...

  7. Jan 26, 2024 · Located in Singapore's Tuas Biomedical Park, AbbVie's Singapore plant is a state-of-the-art small-molecule and biologics manufacturing facility serving markets worldwide.